
Overview
Status
Suspended
Registry date
2007-01-19
Share capital
50,000.00 PLN
Registered address
ul. Dzierżoniowska 5 B, 01-985 Warszawa, Poland
Website
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2023 – the filing deadline has passed. 2 of 5 financial statements were filed late (the longest delay 496 days for 2020).
- 2023not filed
- 202203/02/2023
- 202125/10/2022
- 202023/02/2023
- 201903/07/2020
- 201818/06/2019
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Andrzej Bobola Donde – Management Board Member
Dominika Donde Antepowicz – Wice-Prezes Zarządu
Ewa Maria Donde – President of the Management Board
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Ewa Maria Dondeage 76 | 900 | $12,155.59 | 90% |
Dominika Irena Donde Antepowiczage 51 | 100 | $1,350.62 | 10% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2006-11-24 to 2026-09-08.
Reason for removal: Art. 96 ust. 9a pkt 1 (business activity suspended for at least 6 consecutive months)
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $881$881 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $881$881 | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Novartis Polandsp. z o.o. | $378,147,128.47 | novartis.com | ||
| Bristol-Myers Squibb Polskasp. z o.o. | $230,722,737.87 | bms.com | ||
| Boironsp. z o.o. | $9,932,832.64 | boiron.pl | ||
| Creator-Commsp. z o.o. | $8,811,210.35 | creator-comm.pl | ||
| Billmedsp. z o.o. | $5,738,714.60 | e.pl | ||
| Hair Partnerssp. z o.o. | $4,347,484.74 | hairpartners.pl | ||
| Eumedsp. z o.o. | $2,086,044.24 | eumed.pl | ||
| Farmedicasp. z o.o. | $1,689,796.86 | farmedica.pl | ||
| IHT Polskasp. z o.o. | $566,313.48 | ihtpolska.com | ||
| Mitramed Paweł Wysocki, Piotr Wachaczyksp. j. | $198,282.96 | e.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-02-01 | Business suspended | |
| 2025-01-01 | Business resumed | |
| 2023-01-01 | Business suspended | |
| 2019-12-20 | Address change (Lektykarska 4/A, 01-687, Warszawa → Ul. Dzierżoniowska 5 B, 01-985, Warszawa) | |
| 2019-12-20 | Switch to PKD 2007 (6 PKD 2004 codes → 8 PKD 2007 codes) |
FAQ
The main business activity of Artimed Ltd focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on January 19, 2007.
The headquarters is located at: ul. Dzierżoniowska 5 B, 01-985 Warszawa.
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2022 to December 31, 2022.
Last updated: 2026-04-14